Definium Therapeutics, Inc. Stock Deutsche Boerse AG
Stocks
MMQ0
CA24477V1058
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:02:30 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 31.50 EUR | +0.64% |
|
-0.63% | +180.00% |
| Market Cap | 5.23B 4.5B 4.26B 3.86B 7.25B 499B 7.29B 50.63B 19.47B 254B 19.63B 19.19B 803B | P/E 2026 * |
-12.3x | P/E 2027 * | -19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.19B 3.61B 3.42B 3.1B 5.82B 401B 5.85B 40.64B 15.63B 204B 15.75B 15.41B 644B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 140x |
| Free-Float |
98.26% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DFTX | Delayed | |
CBOE
| DFTX | Real-time | |
|
Tradegate
| MMQ0 | Real-time | |
|
Boerse Muenchen
| MMQ0 | Real-time | |
|
Deutsche Boerse AG
| MMQ0 | Delayed | |
|
Börse Stuttgart
| MMQ0 | Delayed |
Last Transcript : Definium Therapeutics, Inc.
| 1 day | +0.64% | ||
| 1 week | -0.63% | ||
| Current month | -8.70% | ||
| 1 month | -11.76% | ||
| 3 months | +51.44% | ||
| 6 months | +90.91% | ||
| Current year | +180.00% |
| 1 week | 31.3 |  | 33 |
| 1 month | 31.3 | | 38.7 |
| Current year | 11.29 | | 42.7 |
| 1 year | 7.54 | | 42.7 |
| 3 years | 2.22 | | 42.7 |
| 5 years | 1.96 | | 42.7 |
| 10 years | 1.96 | | 75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | 37 | 2021-06-08 |
Brandi Roberts
DFI | Director of Finance/CFO | 52 | 2025-06-01 |
Daniel Karlin
CTO | Chief Tech/Sci/R&D Officer | 46 | 2021-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Barrow
BRD | Director/Board Member | 37 | 2021-12-12 |
Andreas Krebs
BRD | Director/Board Member | 67 | 2021-09-28 |
Carol Vallone
CHM | Chairman | 69 | 2021-12-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.64% | -0.63% | - | - | 5.07B | |
| -0.71% | -6.35% | -4.87% | +9.03% | 46.05B | |
| +0.21% | -2.98% | +340.68% | +519.93% | 43.59B | |
| +1.74% | -2.24% | +37.28% | +21.57% | 42.35B | |
| +1.38% | -3.28% | +3.23% | +65.60% | 38.86B | |
| -1.44% | -5.26% | +8.78% | +36.85% | 32.24B | |
| +0.87% | -2.60% | - | - | 17.16B | |
| +0.75% | -0.64% | +18.07% | +110.32% | 16.28B | |
| -0.31% | -2.78% | +10.47% | +30.49% | 14.32B | |
| +1.93% | -3.55% | +74.20% | +39.37% | 13.03B | |
| Average | +0.51% | -4.23% | +60.98% | +104.14% | 29.32B | |
| Weighted average by Cap. | +0.40% | -4.51% | +73.05% | +123.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 31.42M 27.07M 25.63M 23.23M 43.59M 3B 43.81M 304M 117M 1.53B 118M 115M 4.83B |
| Net income | -376M -324M -307M -278M -522M -35.93B -524M -3.64B -1.4B -18.28B -1.41B -1.38B -57.76B | -268M -231M -219M -198M -372M -25.63B -374M -2.6B -999M -13.04B -1.01B -985M -41.2B |
| Net Debt | -1.03B -888M -841M -762M -1.43B -98.47B -1.44B -9.99B -3.84B -50.1B -3.87B -3.79B -158B | -832M -717M -679M -615M -1.15B -79.46B -1.16B -8.06B -3.1B -40.43B -3.12B -3.06B -128B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | €31.50 | +0.64% | 0 |
| 26-09-10 | €31.30 | -4.28% | 0 |
| 26-09-09 | €32.70 | -0.91% | 0 |
| 26-09-08 | €33.00 | +1.23% | 0 |
| 26-09-07 | €32.60 | +2.84% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DFTX Stock
- MMQ0 Stock
Select your edition
All financial news and data tailored to specific country editions
